Location
United States, North America
Check Size
$10K - $100M
Investment Stage
Series A
Series B
Focus Areas
Health IT
BioTech
About Investor
Vineeta Agarwala is a General Partner at Andreessen Horowitz in San Francisco, writing $10 K–$100 M checks from seed through Series B into biotech and health-IT startups. A practicing physician and former clinical instructor at Stanford, she previously served as a venture partner at GV and led product strategy at Roche’s digital health group, blending medical expertise with tech commercialization.
Previous investments
Gate Bioscience
60M |2023
Arda Therapeutics
43M |2024
Thyme Care
55M |2024
60M |2023
22M |2021
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,NS
Nikhil Shah
United States, North America
$5K - $50K
Seed
,Series A
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free